|
|
|
Raynaud's disease is characterized by intermittent or continuous pallor or cyanosis and coldness of the digits, which is usually bilateral and symmetrical. Western Medicine lacks effective treatment for Raynaud's disease. ACMA has once received a Raynaud's disease patient who was a M.D. herself, but she could not treated her Raynaud's disease by means of Western Medicine. ACMA Treatment for Raynaud's Disease On December 12, 2004, ACMA received a Raynaud's disease patient. ACMA started the CHM treatment on December 16, 2004. On January 9, 2005, the patient reported to ACMA that her Raynaud's disease condition got significantly improved. By January 22, 2005, the patient reported to ACMA that the Raynaud's disease symtoms were almost gone. ACMA then stopped the Raynaud's disease treatment. By July 2006 when the case report was prepared, the patient reported to ACMA that her Raynaud's disease has not relapsed since stopping the CHM treatment. Related links:
|
|